BRPI0811979A2 - Formulação para vacinas de meningite - Google Patents
Formulação para vacinas de meningiteInfo
- Publication number
- BRPI0811979A2 BRPI0811979A2 BRPI0811979-1A2A BRPI0811979A BRPI0811979A2 BR PI0811979 A2 BRPI0811979 A2 BR PI0811979A2 BR PI0811979 A BRPI0811979 A BR PI0811979A BR PI0811979 A2 BRPI0811979 A2 BR PI0811979A2
- Authority
- BR
- Brazil
- Prior art keywords
- formulation
- meningitis vaccines
- meningitis
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93323507P | 2007-06-04 | 2007-06-04 | |
| PCT/IB2008/002121 WO2008149238A2 (en) | 2007-06-04 | 2008-06-04 | Formulation of meningitis vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0811979A2 true BRPI0811979A2 (pt) | 2014-10-21 |
Family
ID=40094241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0811979-1A2A BRPI0811979A2 (pt) | 2007-06-04 | 2008-06-04 | Formulação para vacinas de meningite |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100203137A1 (en:Method) |
| EP (1) | EP2152302B1 (en:Method) |
| JP (1) | JP5637848B2 (en:Method) |
| CN (1) | CN101678094B (en:Method) |
| AU (2) | AU2008259423A1 (en:Method) |
| BR (1) | BRPI0811979A2 (en:Method) |
| CA (1) | CA2688268A1 (en:Method) |
| ES (1) | ES2555786T3 (en:Method) |
| IN (1) | IN2009KN04098A (en:Method) |
| MX (1) | MX2009013112A (en:Method) |
| NZ (1) | NZ581367A (en:Method) |
| RU (1) | RU2009149359A (en:Method) |
| WO (1) | WO2008149238A2 (en:Method) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA00010722A (es) | 1998-05-01 | 2004-12-03 | Chiron Corp | Antigenos de neisseria meningitidis y composiciones que los contienen. |
| CA2838395C (en) | 1999-05-19 | 2016-07-19 | Novartis Vaccines And Diagnostics S.R.L. | Combination neisserial compositions |
| DK2275553T3 (en) | 1999-10-29 | 2015-08-03 | Novartis Vaccines & Diagnostic | Neisserial antigenic peptides |
| BR0108713A (pt) | 2000-02-28 | 2004-06-22 | Chiron Spa | Expressão hìbrida de proteìnas de neisseria |
| HU227613B1 (en) * | 2000-06-29 | 2011-09-28 | Glaxosmithkline Biolog Sa | Vaccine composition |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| LT2351578T (lt) * | 2005-06-27 | 2017-04-10 | Glaxosmithkline Biologicals S.A. | Vakcinų gavimo būdas |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| JP5701058B2 (ja) * | 2007-10-19 | 2015-04-15 | ノバルティス アーゲー | 髄膜炎菌ワクチン処方物 |
| AU2009215364B2 (en) | 2008-02-21 | 2014-09-18 | Glaxosmithkline Biologicals S.A. | Meningococcal fHBP polypeptides |
| EP2303286A4 (en) * | 2008-06-16 | 2011-12-28 | Academia Sinica | COMPOSITIONS FOR GENERATING IMMUNE REACTIONS SPECIFIC TO GLOBO H AND SSEA3 AND THEIR USES IN CANCER TREATMENT |
| GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
| CA2756522C (en) * | 2009-03-24 | 2018-06-26 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
| US20120064103A1 (en) * | 2009-03-24 | 2012-03-15 | Novartis Ag | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| CA2803239A1 (en) | 2010-06-25 | 2011-12-29 | Novartis Ag | Combinations of meningococcal factor h binding proteins |
| HUE034544T2 (hu) | 2010-08-23 | 2018-02-28 | Wyeth Llc | Neisseria meningitidis rLP2086 antigént tartalmazó stabil készítmények |
| JP5976652B2 (ja) | 2010-09-10 | 2016-08-24 | ワイス・エルエルシー | 髄膜炎菌ｏｒｆ２０８６抗原の非脂質化変異体 |
| RU2013131795A (ru) * | 2010-12-10 | 2015-01-20 | Мерк Шарп Энд Домэ Корп. | Новые композиции, которые уменьшают вызываемую встряхиванием агрегацию иммуногенных композиций |
| IN2012MU00206A (en:Method) * | 2012-01-20 | 2013-08-09 | ||
| US9375471B2 (en) * | 2012-03-08 | 2016-06-28 | Glaxosmithkline Biologicals Sa | Adjuvanted formulations of booster vaccines |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| KR101784644B1 (ko) | 2012-03-09 | 2017-10-11 | 화이자 인코포레이티드 | 수막염균 조성물 및 이의 사용 방법 |
| RU2644340C2 (ru) | 2012-06-14 | 2018-02-08 | Новартис Аг | Вакцины для менингококка серогруппы х |
| EP2964665B1 (en) | 2013-03-08 | 2018-08-01 | Pfizer Inc | Immunogenic fusion polypeptides |
| CN105492021B (zh) | 2013-09-08 | 2018-12-04 | 辉瑞公司 | 脑膜炎奈瑟氏球菌组合物及其方法 |
| CN107249626A (zh) | 2015-02-19 | 2017-10-13 | 辉瑞大药厂 | 脑膜炎奈瑟球菌组合物及其方法 |
| PT3506935T (pt) | 2016-09-02 | 2024-04-01 | Sanofi Pasteur Inc | Vacina contra neisseria meningitidis |
| EP3577130A2 (en) | 2017-01-31 | 2019-12-11 | Pfizer Inc | Neisseria meningitidis compositions and methods thereof |
| CN115605222A (zh) | 2019-09-27 | 2023-01-13 | 辉瑞公司（Us） | 脑膜炎奈瑟氏菌组合物及其方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| DK0658118T3 (da) | 1992-08-31 | 2002-05-06 | Baxter Healthcare Sa | Vaccine mod Neisseria meningitidis, gruppe C |
| US5425946A (en) | 1992-08-31 | 1995-06-20 | North American Vaccine, Inc. | Vaccines against group C Neisseria meningitidis |
| GB9422096D0 (en) * | 1994-11-02 | 1994-12-21 | Biocine Spa | Combined meningitis vaccine |
| BRPI9609414B8 (pt) | 1995-06-23 | 2021-05-25 | Smithkline Beecham Biologicals S A | combinação de vacina e kit para produzir a mesma. |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| HU227613B1 (en) | 2000-06-29 | 2011-09-28 | Glaxosmithkline Biolog Sa | Vaccine composition |
| DK2332581T3 (en) | 2001-01-23 | 2015-10-05 | Sanofi Pasteur Inc | Tri- or tetravalent meningococcal polysaccharide-crm197 conjugate vaccine |
| GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| WO2003080678A1 (en) | 2002-03-26 | 2003-10-02 | Chiron Srl | Modified saccharides having improved stability in water |
| CN102319427A (zh) * | 2003-01-30 | 2012-01-18 | 诺华疫苗和诊断有限公司 | 抗多种脑膜炎球菌血清组的可注射性疫苗 |
| PL1961426T3 (pl) | 2003-10-02 | 2012-03-30 | Gsk Vaccines S R L | Skojarzone szczepionki przeciwko zapaleniu opon mózgowo-rdzeniowych |
| GB0405787D0 (en) * | 2004-03-15 | 2004-04-21 | Chiron Srl | Low dose vaccines |
| GB0409745D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Compositions including unconjugated carrier proteins |
| GB0500787D0 (en) * | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| CN1709505B (zh) * | 2005-07-13 | 2010-06-16 | 北京绿竹生物制药有限公司 | 多价细菌荚膜多糖-蛋白质结合物联合疫苗 |
| MX348734B (es) * | 2005-09-01 | 2017-06-27 | Novartis Vaccines And Diagnostics Gmbh & Co Kg | Vacunacion multiple que incluye meningococcus del serogrupo c. |
| GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| JP5701058B2 (ja) * | 2007-10-19 | 2015-04-15 | ノバルティス アーゲー | 髄膜炎菌ワクチン処方物 |
-
2008
- 2008-06-04 CA CA2688268A patent/CA2688268A1/en not_active Abandoned
- 2008-06-04 BR BRPI0811979-1A2A patent/BRPI0811979A2/pt not_active IP Right Cessation
- 2008-06-04 MX MX2009013112A patent/MX2009013112A/es active IP Right Grant
- 2008-06-04 AU AU2008259423A patent/AU2008259423A1/en not_active Abandoned
- 2008-06-04 RU RU2009149359/15A patent/RU2009149359A/ru not_active Application Discontinuation
- 2008-06-04 CN CN200880018507.2A patent/CN101678094B/zh not_active Expired - Fee Related
- 2008-06-04 ES ES08789070.3T patent/ES2555786T3/es active Active
- 2008-06-04 US US12/451,831 patent/US20100203137A1/en not_active Abandoned
- 2008-06-04 WO PCT/IB2008/002121 patent/WO2008149238A2/en not_active Ceased
- 2008-06-04 EP EP08789070.3A patent/EP2152302B1/en active Active
- 2008-06-04 NZ NZ581367A patent/NZ581367A/en not_active IP Right Cessation
- 2008-06-04 IN IN4098KON2009 patent/IN2009KN04098A/en unknown
- 2008-06-04 JP JP2010510910A patent/JP5637848B2/ja not_active Expired - Fee Related
-
2014
- 2014-07-15 AU AU2014204425A patent/AU2014204425B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN101678094B (zh) | 2014-08-27 |
| AU2014204425B2 (en) | 2015-10-29 |
| WO2008149238A3 (en) | 2009-08-06 |
| US20100203137A1 (en) | 2010-08-12 |
| CA2688268A1 (en) | 2008-12-11 |
| EP2152302B1 (en) | 2015-10-07 |
| JP5637848B2 (ja) | 2014-12-10 |
| AU2008259423A1 (en) | 2008-12-11 |
| JP2010529103A (ja) | 2010-08-26 |
| AU2014204425A1 (en) | 2014-08-07 |
| CN101678094A (zh) | 2010-03-24 |
| WO2008149238A2 (en) | 2008-12-11 |
| IN2009KN04098A (en:Method) | 2015-08-28 |
| EP2152302A2 (en) | 2010-02-17 |
| ES2555786T3 (es) | 2016-01-08 |
| RU2009149359A (ru) | 2011-07-20 |
| MX2009013112A (es) | 2010-03-01 |
| NZ581367A (en) | 2012-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0811979A2 (pt) | Formulação para vacinas de meningite | |
| DK2234600T3 (da) | Antistofformulering | |
| DK3072906T3 (da) | Antistofformulering | |
| EP2358392A4 (en) | ANTIBODY FORMULATION | |
| EP2150167A4 (en) | SEMI-DISPOSABLE ENDOSCOPE | |
| BRPI0920240A2 (pt) | formulação de adjuvante de combinação | |
| BRPI0918971A2 (pt) | tienopirimidinas para composições farmacêuticas | |
| DK2346495T4 (da) | Farmaceutisk formulering 514 | |
| BRPI0814252A2 (pt) | Formulações de anticorpo | |
| PT2889310T (pt) | Formulações de anticorpo | |
| BRPI0814188A2 (pt) | Formulações | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| BRPI0909492A2 (pt) | dispositivo para produção de chocolate | |
| BRPI0906946A2 (pt) | Vacinas baseadas em baculovírus | |
| BRPI0818669A2 (pt) | formulação para melhora da função gastrintestinal | |
| EP2207567A4 (en) | IMMUNOGENIC FORMULATIONS | |
| BRPI0811732A2 (pt) | Formulação de liberação prolongada de nevirapina | |
| BRPI0912656A2 (pt) | formulação farmacêutica sólida | |
| BRPI0822199A2 (pt) | Formulação herbicida | |
| ES1067730Y (es) | Dispositivo autoblocante para persiana | |
| ES1065835Y (es) | Caperuza para cetreria | |
| ES1070237Y (es) | "dispositivo antiseismos para la construccion" | |
| ES1063735Y (es) | Testero para persiana | |
| ES1065263Y (es) | Captafaros para bionda | |
| ES1065984Y (es) | Dispositivo de sujecion para muñecos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 39/102 (2006.01), A61K 39/02 (2006.01), A61K |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2517 DE 02-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |